Pilot study of the combination of melphalan, carboplatin and etoposide as a conditioning regimen for relapsed lymphoma patients

被引：5

作者：

del Giglio, A

Costa, LJM

Pinczowski, H

Varella, PCS

Luzzi, JR

Neves, P

Mota, A

Boente, P

Sampaio, C

机构：

[1] ABC Fdn, Sch Med, BR-01444001 Sao Paulo, Brazil

[2] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil

[3] Samaritan Hosp, Blood Bank, Sao Paulo, Brazil

[4] Grp Estud Med, Sao Paulo, Brazil

来源：

ACTA HAEMATOLOGICA | 1999年 / 102卷 / 01期

关键词：

D O I：

10.1159/000040969

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：56 / 58

页数：3

共 13 条

[11]

VELASQUEZ WS, 1988, BLOOD, V71, P117

[12] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA [J].

VOSE, JM ;

ANDERSON, JR ;

KESSINGER, A ;

BIERMAN, PJ ;

COCCIA, P ;

REED, EC ;

GORDON, B ;

ARMITAGE, JO .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :1846-1851

[13] High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin's lymphoma: results of outpatient treatment in community cancer centers [J].

Weaver, CH ;

Schwartzberg, L ;

Zhen, B ;

Mangum, M ;

Leff, R ;

Tauer, K ;

Rosenberg, A ;

Pendergrass, K ;

Kaywin, P ;

Hainsworth, J ;

Greco, FA ;

West, WH ;

Buckner, CD .

BONE MARROW TRANSPLANTATION, 1997, 20 (09) :753-760

← 1 2 →